High level concentration of pyrimidine nucleotide phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters

Diseases of the Esophagus

Volumn 16, Issue 4, 2003, Pages 307-311

  Noguchi, T ^a   Moriyama, H ^a   Wada, S ^a   Takeno, S ^a   Kimura, Y ^a   Uchida, Y ^a   Gabbert, H E ^b  

^a OITA UNIVERSITY   (Japan)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

5 Deoxy 5 fluorouridine; Dihydropyrimidine dehydrogenase; Esophageal carcinoma; Pyrimidine nucleoside phophorylase; Survival

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; DOXIFLURIDINE; PROTEIN; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; FROZEN SECTION; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DIHYDROURACIL DEHYDROGENASE (NADP); ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; PENTOSYLTRANSFERASES; PROGNOSIS;

EID: 0346655385     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2003.00352.x     Document Type: Article

References (23)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? Natl Cancer Inst 1990; 82: 4-6.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10 931-4.
3. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338: 557-62.
4. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S. Angiogenetic factor. Nature 1992; 356: 668.
5. Haraguchi M, Miyadera K, Uemura K et al. Angiogenic activity of enzymes. Nature 1994; 368: 198.
6. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 1995; 92: 1-7.
7. Shomori K, Sakatani T, Goto A, Matsuura T, Kiyonari H, Ito H. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: Role of p53 expression. Pathol Int 1999; 49: 491-9.
8. Takebayashi Y, Miyadera K, Akiyama S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996; 87: 288-95.
9. Maeda K, Chung Y S, Ogawa Y et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73: 884-8.
10. Imazono Y, Takebayashi Y, Nishiyama K et al. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997; 15: 2570-8.
11. Ueda M, Terai Y, Kumagai K, Ueki K, Okamoto Y, Ueki M. Correlation between tumor angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma. Hum Pathol 1999; 30: 1389-94.
12. Koide N, Watanabe H, Yazawa K, Adachi W, Amano J. Immunohistochemical expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus. Hepatogastroenterology 1999; 46: 944-51.
13. Takebayashi Y, Natsugoe S, Baba M, et al. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 1999; 85: 282-9.
14. Igarashi M, Dhar D K, Kubota H, Yamamoto A, El-Assal O, Nagasue N. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998; 82: 1225-32.
15. Okamoto E, Osaki M, Kase S, Adachi H, Kaibara N, Ito H. Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas. Pathol Int 2001; 51: 158-64.
16. Ikeguchi M, Oka S, Saito H, et al. Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas. Eur Surg Res 1999; 31: 357-63.
17. Fleming R A, Milano G, Thyss A et al. Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res 1992; 52: 2899-902.
18. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 1998; 58: 685-90.
19. Mori K, Hasegawa M, Nishida M et al. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 2000; 17: 33-8.
20. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996; 19: 1407-11.
21. Shimada H, Takeda A, Shiratori T, et al. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer 2002; 94: 1947-54.
22. Matsuura T, Kuratake I, Teramachi K, Osaki M, Fukuda Y, Ito H. Thymidine phosphorylase expression is associated with both increase of intratumoral micro vessels and decrease of apoptosis in human colorectal carcinomas. Cancer Res 1999; 59: 5037-40.
23. Osaki M, Sakatani T, Okamoto E, Goto E, Adachi H, Ito H. Thymidine phosphorylase (dThPase) expression results in a decrease in apoptosis and increase in intratumoral microvessels (IMVD) in human gastric carcinomas. Virchows Arch 2000; 437: 31-6.